SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-203392
Filing Date
2022-07-27
Accepted
2022-07-27 16:05:23
Documents
89
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d360666d10q.htm   iXBRL 10-Q 3469346
2 EX-31.1 d360666dex311.htm EX-31.1 10405
3 EX-31.2 d360666dex312.htm EX-31.2 10390
4 EX-32 d360666dex32.htm EX-32 4306
  Complete submission text file 0001193125-22-203392.txt   13377660

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20220630.xsd EX-101.SCH 82032
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20220630_cal.xml EX-101.CAL 47324
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20220630_def.xml EX-101.DEF 522254
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20220630_lab.xml EX-101.LAB 552554
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20220630_pre.xml EX-101.PRE 559668
83 EXTRACTED XBRL INSTANCE DOCUMENT d360666d10q_htm.xml XML 2916096
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 221111035
SIC: 2834 Pharmaceutical Preparations